These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Opioid Mechanisms and the Treatment of Depression. Jelen LA; Young AH; Mehta MA Curr Top Behav Neurosci; 2024; 66():67-99. PubMed ID: 37923934 [TBL] [Abstract][Full Text] [Related]
6. Endogenous opioid system: a promising target for future smoking cessation medications. Norman H; D'Souza MS Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326 [TBL] [Abstract][Full Text] [Related]
7. Involvement of opioid system in behavioral despair induced by social isolation stress in mice. Haj-Mirzaian A; Nikbakhsh R; Ramezanzadeh K; Rezaee M; Amini-Khoei H; Haj-Mirzaian A; Ghesmati M; Afshari K; Haddadi NS; Dehpour AR Biomed Pharmacother; 2019 Jan; 109():938-944. PubMed ID: 30551548 [TBL] [Abstract][Full Text] [Related]
8. 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse. Charbogne P; Kieffer BL; Befort K Neuropharmacology; 2014 Jan; 76 Pt B(0 0):204-17. PubMed ID: 24035914 [TBL] [Abstract][Full Text] [Related]
9. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. Carlezon WA; Krystal AD Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938 [TBL] [Abstract][Full Text] [Related]
10. A role for the mu opioid receptor in the antidepressant effects of buprenorphine. Robinson SA; Erickson RL; Browne CA; Lucki I Behav Brain Res; 2017 Feb; 319():96-103. PubMed ID: 27818236 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the central opioid system as an antidepressant target in rodent models. McHugh KL; Kelly JP Prog Brain Res; 2018; 239():49-87. PubMed ID: 30314569 [TBL] [Abstract][Full Text] [Related]
12. Opioid systems in the dentate gyrus. Drake CT; Chavkin C; Milner TA Prog Brain Res; 2007; 163():245-63. PubMed ID: 17765723 [TBL] [Abstract][Full Text] [Related]
14. The opioid system in depression. Jelen LA; Stone JM; Young AH; Mehta MA Neurosci Biobehav Rev; 2022 Sep; 140():104800. PubMed ID: 35914624 [TBL] [Abstract][Full Text] [Related]
17. Targeting opioid dysregulation in depression for the development of novel therapeutics. Browne CA; Lucki I Pharmacol Ther; 2019 Sep; 201():51-76. PubMed ID: 31051197 [TBL] [Abstract][Full Text] [Related]
18. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Martin M; Matifas A; Maldonado R; Kieffer BL Eur J Neurosci; 2003 Feb; 17(4):701-8. PubMed ID: 12603260 [TBL] [Abstract][Full Text] [Related]
19. Label-free cell phenotypic study of opioid receptors and discovery of novel mu opioid ligands from natural products. Hou T; Xu F; Peng X; Zhou H; Zhang X; Qiu M; Wang J; Liu Y; Liang X J Ethnopharmacol; 2021 Apr; 270():113872. PubMed ID: 33485984 [TBL] [Abstract][Full Text] [Related]